A Fulminant Malignant Hyperthermia Episode in a Patient with Ryanodine Receptor Gene Mutation p.Tyr522Ser
Authors:
- Thierry GirardTGThierry Girard
- Markus SuhnerMSMarkus Suhner
- Soledad LevanoSLSoledad Levano
- Martine SingerMSMartine Singer
- Andreas ZollingerAZAndreas Zollinger
- Christoph K. HoferCHChristoph K. Hofer
- 1 December 2008
- journal article
- case report
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 107 (6) , 1953-1955
Abstract
A 37-yr-old patient scheduled for elective bursectomy developed fulminant malignant hyperthermia (MH) under sevoflurane anesthesia. The first sign was a dramatic increase in end-tidal CO2. Symptomatic and specific therapy was rapidly instituted. Postoperative rhabdomyolysis was treated with veno-venous hemofiltration. The patient rejected open muscle biopsy for in vitro contracture testing. Therefore, molecular testing was performed. An infrequent MH causative mutation was identified on the ryanodine receptor gene. This case report confirms the causative nature of this mutation. It also shows that molecular genetic investigation may be as appropriate as in vitro contracture testing to confirm the diagnosis after a clinical episode of MH.Keywords
This publication has 11 references indexed in Scilit:
- Mutations inRYR1in malignant hyperthermia and central core diseaseHuman Mutation, 2006
- Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibilityHuman Mutation, 2005
- Malignant HyperthermiaJAMA, 2005
- Molecular Genetic Testing for Malignant Hyperthermia SusceptibilityAnesthesiology, 2004
- Malignant hyperthermiaEuropean Journal of Anaesthesiology, 2001
- Guidelines for molecular genetic detection of susceptibility to malignant hyperthermiaBritish Journal of Anaesthesia, 2001
- Caffeine and Halothane Sensitivity of Intracellular Ca2+ Release Is Altered by 15 Calcium Release Channel (Ryanodine Receptor) Mutations Associated with Malignant Hyperthermia and/or Central Core DiseaseJournal of Biological Chemistry, 1997
- Mutation Screening of the RYR1 Gene in Malignant Hyperthermia: Detection of a Novel Tyr to Ser Mutation in a Pedigree with Associated Central CoresGenomics, 1994
- A Clinical Grading Scale to Predict Malignant Hyperthermia SusceptibilityAnesthesiology, 1994
- ANÆSTHETIC DEATHS IN A FAMILYThe Lancet, 1960